Sign In
Buy ZTS
$77.59
+1.20 (+1.57%)
At Close: Jun 03, 2026
2 Dividend Stocks That Doubled Their Payouts in 5 Years
05:27am, Wednesday, 19'th Jul 2023
Zoetis and Mastercard don't offer high yields, but both aggressively raised their payouts in recent years. Both companies have modest payout ratios, suggesting more hikes could be on the way.
JAZZ vs. ZTS: Which Stock Is the Better Value Option?
01:17pm, Tuesday, 11'th Jul 2023
Investors interested in stocks from the Medical - Drugs sector have probably already heard of Jazz Pharmaceuticals (JAZZ) and Zoetis (ZTS). But which of these two stocks offers value investors a bette
Wall Street Analysts Believe Zoetis (ZTS) Could Rally 27.94%: Here's is How to Trade
11:32am, Wednesday, 05'th Jul 2023
The average of price targets set by Wall Street analysts indicates a potential upside of 27.9% in Zoetis (ZTS). While the effectiveness of this highly sought-after metric is questionable, the positive
My Top 15 High Growth Dividend Stocks For July 2023
11:20am, Monday, 03'rd Jul 2023
The watchlist from June posted a gain of 8.91% last month, outperforming the SPDR S&P 500 Trust ETF by 2.43% and Vanguard's Dividend Appreciation ETF by 2.41%. The top 15 dividend growth stocks for Ju
Zoetis to Host Webcast and Conference Call on Second Quarter 2023 Financial Results
08:30am, Friday, 30'th Jun 2023
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Tuesday, Aug. 8, 2023. Chief Executive Officer Kristin Pec
Zoetis (ZTS) Just Reclaimed the 20-Day Moving Average
10:36am, Wednesday, 28'th Jun 2023
After reaching an important support level, Zoetis (ZTS) could be a good stock pick from a technical perspective. ZTS surpassed resistance at the 20-day moving average, suggesting a short-term bullish
There Are Plenty of Reasons to Like Zoetis
11:50am, Tuesday, 27'th Jun 2023
Zoetis Inc. ( ZTS , Financial) is a leading animal health company with a diversified product portfolio of medicines and vaccines that aim to treat and protect livestock and companion animals.
Zoetis: A Purrfect Addition To Your Portfolio
01:47am, Thursday, 22'nd Jun 2023
Zoetis, a global leader in the animal health industry, has beaten the S&P 500 over the last five years and offers diverse growth opportunities. The company has a strong international presence, a commi
History Suggests This S&P 500 Dividend Stock Is Perfect to Buy and Hold Forever
09:15am, Wednesday, 21'st Jun 2023
Zoetis has more than doubled the S&P 500's return over the past decade. The animal health company's return on invested capital has risen to over 18%.
My Top 15 High Growth Dividend Stocks For June 2023
08:54am, Saturday, 03'rd Jun 2023
I present my top 15 high-growth dividend stocks to consider during the month of June. The watchlist underperformed VIG in May, but continues to outpace the ETF year-to-date and since inception. Five n
Zoetis' Dividend Growth: Small Yield, Big Returns
11:44am, Wednesday, 10'th May 2023
The article discusses Zoetis, a low-yielding dividend stock with high dividend growth potential. Zoetis is the world's leading producer of medicine and vaccinations for pets and livestock, with a glob
Zoetis (ZTS) Q1 Earnings Top Estimates
09:55am, Thursday, 04'th May 2023
Zoetis (ZTS) came out with quarterly earnings of $1.31 per share, beating the Zacks Consensus Estimate of $1.27 per share. This compares to earnings of $1.32 per share a year ago.
Zoetis Tumbles As Spot's Drugmaker Reports Mixed Earnings, Though Keeps Outlook
09:27am, Thursday, 04'th May 2023
Animal health behemoth Zoetis reported a mixed first quarter but kept its full-year outlook. Still, ZTS stock tumbled early Thursday.
Zoetis Stock Falls Amid Mixed Earnings Report
07:35am, Thursday, 04'th May 2023
The animal health provider maintained its guidance for full year 2023 after first quarter earnings beat expectations.
My Top 15 High-Growth Dividend Stocks For May 2023
12:30pm, Monday, 01'st May 2023
I present my top 15 high-growth dividend stocks to consider during the month of May. The watchlist posted a gain of 0.41% in April, trailing both VIG and SPY.
